Disease: Prostatic Neoplasms ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.350 Biomarker group CTD_human The long tail of oncogenic drivers in prostate cancer. 29610475 2018
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.350 AlteredExpression group LHGDN Inactivation of AR activates HGF/c-Met system in human prostatic carcinoma cells. 16870139 2006
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.350 Biomarker group LHGDN Involvement of HGF/SF-Met signaling in prostate adenocarcinoma cells: evidence for alternative mechanisms leading to a metastatic phenotype in Pr-14c. 15678502 2005
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.350 AlteredExpression group LHGDN Prostate cancer and the met hepatocyte growth factor receptor. 15327888 2004
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.350 Biomarker group LHGDN Immunohistochemical expression of hepatocyte growth factor and c-Met/HGF receptor in benign and malignant human prostate tissue. 12883672 2004
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.350 AlteredExpression group BEFREE We found that CAV1, CAV2, MET and TES mRNA expression was lower in prostate tumors than in normal prostate tissues. 15252854 2004